Originally published In Press as doi:10.1074/jbc.M000700200 on April 5, 2000
J. Biol. Chem., Vol. 275, Issue 26, 19585-19593, June 30, 2000
GABAA and
-Amino-3-hydroxy-5-methylsoxazole-4-propionate Receptors Are
Differentially Affected by Aging in the Rat Hippocampus*
Diego
Ruano
,
Francisco
Araujo
,
Elisa
Revilla
,
Jose
Vela
,
Olivier
Bergis§, and
Javier
Vitorica
¶
From the
Departamento Bioquimica, Bromatologia y
Toxicologia. Facultad de Farmacia, Universidad de Sevilla,
41012 Seville, Spain and the § Central Nervous System
Research Department Synthelabo Recherche,
Rueil-Malmaison 92225, France
Received for publication, January 31, 2000, and in revised form, April 4, 2000
 |
ABSTRACT |
We have investigated the
age-dependent modifications in the expression of eight
different subunits of the
-aminobutyric acid, type A
(GABAA) receptor (
1,
2,
3,
5,
2,
3,
2S, and
2L) and all four subunits of the
-amino-3-hydroxy-5-methylsoxazole-4-propionate (AMPA) receptor
(GluR1-4) in the hippocampus of 24-month-old rats. All aged hippocampi
displayed a remarkable increase (aged/adult ratio, 3.53 ± 0.54)
in the mRNA levels of the short version of the
2 subunit in
parallel with a similar increase in the
2 subunit protein
(aged/adult ratio, 2.90 ± 0.62). However, this increase was not
observed in the mature receptor. On the other hand, the expression of
the different
subunit mRNAs increased moderately with aging,
displaying a heterogeneous pattern. The most frequent modification
consisted in an increase in the expression of the
1 subunit mRNA
(aged/adult ratio, 1.26 ± 0.18), in parallel with a similar
increase on the
1 protein (aged/adult ratio, 1.27 ± 0.12) and
in the
1 incorporated to the assembled GABAA receptor (tested by immunoprecipitation; aged/adult ratio, = 1.20 ± 0.10). However, in the same hippocampal samples, no major modifications were
observed on the expression of the AMPA receptor subunits. As a whole,
these results indicated the existence of an increased expression of the
GABAA receptor subunits and a preservation of the AMPA
receptor at the hippocampal formation. These modifications could
reflect the existence of specific deficiencies (neuronal loss and/or
deafferentiation) on the GABAergic system in the aged rats.
 |
INTRODUCTION |
Normal aging is associated with memory and/or learning impairments
that could reflect modifications at the hippocampal formation (1). The
GABAA1 and AMPA
receptors (major fast inhibitory and excitatory receptor complexes,
respectively) could be implicated in these alterations (2, 3).
Both neurotransmitter receptors are composed of a high number of
subunits in a, probably, pentameric or tetrameric conformation. The
GABAA receptors are formed by the combination of a total of 19 subunits grouped in eight families:
1-6,
1-3,
1-3,
,
1-3,
,
, and
(Ref. 5; for a review, see Ref. 4). The
AMPA-preferring ionotropic glutamate receptor is composed by four
subunits (GluR1-4) displaying different splicing isoforms (for a
review, see Ref. 6). This high molecular heterogeneity can generate
multiple receptor isotypes, displaying particular physiological and
pharmacological properties.
It is known that the sensitivity for benzodiazepines
(anxiolytic/hypnotic drugs that interact to the GABAA
receptor) increase during aging in humans and in rodents (7). Previous
work from our group has demonstrated the existence of aging-associated
modifications in both the pharmacological properties and the molecular
composition of the GABAA receptors in rat hippocampus
(8-10). These changes could reflect a sensitization process of the
GABAA receptor (see also Ref. 11). However, the
age-dependent modifications on the expression of the
different subunits of the GABAA receptor are currently
unknown. This lack of knowledge is probably due to both the high number
of subunits expressed at the hippocampal formation and the
heterogeneity of the aging process. On the other hand, the excitatory
glutamate receptors, especially AMPA-preferring glutamate receptors,
seem to be less vulnerable to normal aging, as revealed by the absence
of modifications on its binding properties (12-14). Therefore, the
hippocampal GABAergic system seems to be preferentially affected in the
aged rats (Ref. 15 and references therein).
Aiming at obtaining an extensive and global knowledge of the possible
age-dependent alterations in the expression of both GABAA and AMPA receptors, we have quantified, using reverse
transcription (RT)-PCR, the expression of 18 different mRNAs
implicated on both the GABAergic system and the AMPA receptor in each
hippocampal sample. We are aware that aging also displays anatomical
heterogeneity (10, 15, 16), and with our approach, we cannot resolve
these modifications. However, we have analyzed the expression of eight GABAA receptor subunits (
1,
2,
3,
5,
2,
3,
2S, and
2L, the most abundantly expressed subunits at the
hippocampal formation) and all four AMPA-preferring glutamate receptor
subunits (GluR1-4), including their flip and flop variants, together
with both GAD isoenzymes in the same hippocampus from adults and
24-month-old rats. Furthermore, using the same samples, we have also
quantified the relative abundance of two subunit proteins (
1 and
2 subunits) of the GABAA receptor complex that
consistently increased during aging. In all, we have obtained a
significant amount of information about the age-dependent
modifications of the expression of different subunits of the two
major fast neurotransmitter receptors.
 |
MATERIALS AND METHODS |
Hippocampus Isolation--
Adult (3 months) and aged (24 months)
Wistar rats were killed by decapitation, and the hippocampi were
rapidly dissected and frozen in liquid N2. The hippocampi
were stored at -80 °C until use.
RNA and Protein Extraction--
Total RNA and proteins were
extracted using the TripureTM isolation reagent (Roche
Molecular Biochemicals) kit, according to the instructions of the
manufacturer. This procedure allows the isolation of total RNA, DNA,
and protein fractions from a single sample. The contaminating DNA in
the RNA samples was removed by incubation with DNase and confirmed by
PCR analysis of total RNA samples prior to RT. After isolation, the
integrity of the RNA samples were assessed by agarose gel
electrophoresis. The yield of total RNA was determined by measuring the
absorbance (260/280 nm) of ethanol-precipitated aliquots of the
samples. The recovery of RNA was similar for both young and old
hippocampi (not shown).
To analyze the protein fraction, the protein pellets obtained using the
TripureTM isolation reagent, from adult and aged
hippocampus, were resuspended in 1% SDS, 10 mM Tris-HCl,
pH 7.4. The total recovery and integrity of these fractions were
determined as (17) and SDS-polyacrylamide gel electrophoresis.
Competitive RT-PCR--
RT was performed in 10 mM
Tris-HCl, pH 8.3, 50 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol, 1 mM
dNTPs, 1 mM random hexamers, 50 units of ribonuclease
inhibitor, and 100 units of AMV-RT (Roche Molecular Biochemicals) in a
final volume of 20 µl and 1 µg of total RNA as template. After RT,
samples were treated with RNase, and free nucleotides were eliminated
using GlassMAX spin cartridges (Life Technologies, Inc.). As control of
the efficiency in the RT, samples from adult and aged hippocampi were
reverse-transcribed as described above but in presence of 2 µM digoxigenin-dUTP, and the purified cDNA was dotted
on Nylon membranes and developed (see below). The films were scanned
and the adult and aged samples were compared. The results (aged/adult
ratio, 1.10 ± 0.40, n = 11) demonstrated a
similar RT efficiency in both ages.
Competitive RT-PCR was performed basically as described (18). Briefly,
aliquots of hippocampal cDNA (100 ng/tube) and known quantities of
internal standards, corresponding to the
1,
2,
3,
5,
2,
3,
2S, and
2L GABAA receptor subunits, were mixed in different tubes with increasing amount of internal standards. Each
internal standard consisted of the same sequence amplified in the
native subunit, but modified by the inclusion of a BglII restriction site, cloned into pGEM-1 plasmids (kind gifts from Dr.
Dennis R. Grayson) (19). For each GABAA receptor subunit, the range of internal standard quantities was established in control experiments using adult hippocampus. For each subunit, the range was as
follows: 10-1000 fg for
1,
3,
5,
2, and
3; 100-1000 fg
for
2; and 10-10,000 fg for
2 (S or L isoforms).
The PCR was performed in a final volume of 50 µl, using
Taq polymerase, 2.5 units, in the buffer supplied by the
manufacturer (Ecogen); 1.5, 2, or 3 mM MgCl2,
for the
,
, or
subunits, respectively, including 1 µM each 5' (sense) and 3' (antisense) of the respective
primers pairs (20); and 50 µM dNTPs with the addition of
2 µM digoxigenin-dUTP (Roche Molecular Biochemicals). Internal standards and cDNA were heat-denatured for 5 min at
94 °C, and tubes were kept on ice until ready for PCR. The PCR was performed with 30 cycles consisting of 94 °C for 45 s, 60 °C
for 45 s, and 72 °C for 50 s, followed by a final
elongation period of 5 min at 72 °C in a Techne Progene Thermal
Cycler. The PCR products (5-10 µl) were digested overnight with 10 units of BglII and separated on a 1.7% agarose gel in 0.5×
Tris-borate-EDTA buffer. After electrophoresis, the PCR products were
transferred onto a Hybond-N+ nylon membrane (Amersham
Pharmacia Biotech) using a vacuum blotting system,
VacuGeneTM XL (Amersham Pharmacia Biotech) for 1 h at
50 mbar of pressure. The nylon membranes were blocked, incubated with
an anti-digoxigenine antibody conjugated with peroxidase (dilution,
1/20,000; Roche Molecular Biochemicals), washed with Tween 0.1% in
phosphate-buffered saline, and processed for chemiluminescence
detection using the ECL-plus (Amersham Pharmacia Biotech) following the
instructions of the manufacturer. Films were developed and scanned with
a laser densitometer (Molecular Dynamics, model 300 A). Bands for both native cDNA (uncut band) and internal standard (cut band) were analyzed, and the data are the ratio between internal standard and
native cDNA (see Fig. 1). All subunits were determined in at least
duplicate, and for each experiment, a minimum of one adult and one aged
samples were processed and analyzed in parallel.
Control experiments for the efficiency of the transference, second
antibody dilution, and film exposure were performed. In all cases, we
found a linear correlation between the amount of PCR products and the
detected absorbance on the films (not shown).
Quantification of the AMPA Subunits and Flip/Flop Relative
Proportions--
The same samples used for the PCR amplification of
the GABAA receptor subunits, from adult and aged rat
hippocampus, were amplified using primers common to GluR1-4 (sense
primer, CCTTTGGCCTATGAGATCTGGATGTG; antisense primer,
TCGTACCACCATTTGTTTTTCA) with 35 PCR cycles, as described (20), but
including 2 µM digoxigenin-dUTP. The PCR products, 750 bp, (10 µl per subunit) were digested by BglI, BanII, Eco47III, or EcoRI restriction
enzymes, which specifically cut the GluR1 (300 and 449 bp), GluR2 (478 and 271 bp), GluR3 (359 and 396 bp), or GluR4 (411 and 338) PCR
fragments, respectively. The restriction products were separated on a
1.7% agarose gel and transferred to Hybond membranes, and the films
were generated and processed as described above. Quantification was
performed for each electrophoresis lane, corresponding to a
subunit-specific digestion, by summing the absorbance values of cut and
uncut bands and normalizing to 100%. Thus, the percentage of the cut
bands corresponds to the proportion of GluR1-4 subunits present in the PCR-amplified product.
The total amount of all four AMPA receptor subunits was estimated by
quantifying the total, undigested PCR products. For comparative proposes, the results were normalized by the abundance of the
-actin
(see below).
Flip/flop proportion of the GluR1-4 subunits was quantified using the
product of the first PCR (see above) as a template for a second PCR (in
the presence of 2 µM digoxigenin-dUTP). Specific sense
primers for either GluR1, -2, -3, or -4 and the common antisense primer
was that used for the first amplification. The PCR products (632, 639, 628, and 630 bp, corresponding to GluR1, -2, -3 and -4, respectively
(both flip and flop in all cases)) were then cut with subunit specific
enzymes (BglI for GluR1 flip and GluR2 flop, and
HpaI for GluR3 flop and GluR4 flop (20, 21)) and processed
as described above.
GAD65/67 and
-Actin Quantification--
Both isoforms of the
glutamic acid decarboxylase (GAD65 and GAD67) were amplified from the
same cDNA samples as for GABAA, and AMPA receptors. For
the detection of GAD65 and GAD67 mRNAs, the following set of
specific primers were used, from 5' to 3': GAD65 sense,
TCTTTTCTCCTGGTGGTGCC (position 713); GAD65 antisense, CCCCAAGCAGCATCCACAT (position 1085); GAD67 sense, TACGGGGTTCGCACAGGTC (position 713); GAD67 antisense, CCCCAAGCAGCATCCACAT
(position 1159). The same antisense primer was used for the
amplification of both GAD65 and GAD67. This primer had one mismatch
with the sequence of the GAD67, as indicated by the underlined base
(21). The PCR products were processed as described above. The results were normalized by the expression of a housekeeper gene,
-actin.
The
-actin was amplified using the specific primer pairs, from 5' to
3': sense, CGGAACCGCTCATTGCC; antisense, ACCCACACTGTGCCCATCTA. PCR was
performed in the presence of 2 µM digoxigenin-dUTP.
In all cases, the GAD65, GAD67, AMPA, and
-actin were amplified,
electrophoresed, and processed in parallel. In addition, samples for
adult and aged rats were also processed and analyzed in parallel. For
quantification, three different cDNA dilutions were used, and 20, 25, and 30 cycles of PCR were run in order to avoid the problem of band saturation.
Membrane Preparation and Receptor
Solubilization--
Hippocampal membranes from 3- and 24-month-old
Wistar rats were prepared by ultracentrifugation at 100,000 × g as described elsewhere (8, 22, 23 and ref. therein) in
presence of protease inhibitors: 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM
benzamidine, 50 µg/ml trypsin inhibitor type II-S, and 50 µg/ml bacitracin.
The GABAA receptor was solubilized at 1 mg of protein/ml,
4 °C for 60 min, with 0.5% (w/v) sodium deoxycholate, 0.5% (w/v) CHAPS, 140 mM NaCl, and 10 mM Tris-HCl, pH 7.5, containing the same protease inhibitors as above. After centrifugation
at 100.000 × g, for 60 min at 4 °C, the supernatant
was collected. Previous work has demonstrated the absence of subunit
redistribution using this solubilization conditions (24).
Antibody Purification and Immunoprecipitations--
When needed,
the anti-
1 and anti-
2 antibodies (24, 25) were purified through
peptide affinity columns. The peptides were coupled to CNBr-activated
Sepharose 4B (Amersham Pharmacia Biotech). One ml of the different
antisera (diluted 1/5 in phosphate-buffered saline) were recirculated
overnight at 4 °C in the corresponding column (1 ml). After washing
with 150 ml phosphate-buffered saline, the antibodies were eluted with
50 mM glycine-HCl, pH 2.3, and the fractions (0.5 ml) were
neutralized by 1 M Tris, pH 11, pooled, and dialyzed
against 1 liter of phosphate-buffered saline overnight at 4 °C.
Prior to utilization, saturating amounts (not shown) of the different
antibodies were adsorbed to 50 µl of a suspension of protein
A-Sepharose (10% (w/v) in solubilization buffer; see also Refs. 24 and
25). The immunoprecipitations were done as described (24, 25).
The immunoprecipitation was quantified by determining the binding
activity of 10 nM [3H]flumazenil (total
benzodiazepine receptors) in both pellets and the final supernatants.
The binding assays were done essentially as described previously
(23).
Immunoaffinity Chromatography--
It is known that the
2
subunit displays an anomalous electrophoretic behavior in
SDS-polyacrylamide gel electrophoresis (26, 27), and it is difficult to
detect in Western blots (28). Thus, the
2 subunit from adult and
aged hippocampus was first immunopurified through anti-
2 affinity
columns (our anti-
2 antibody was made against a peptide of the
N-terminal domain of the protein, and thus, it recognizes both short
and long isoforms). The anti-
2 immunoaffinity columns were
synthesized as described (25). Fab fragments of the purified anti-
2
antibodies were used in order to avoid any possible interference with
the IgG heavy chain (55 kDa). The Fab fragments were prepared using
papain-agarose (Pierce) as recommended by the manufacturer. The Fab
immunoaffinity columns were synthesized using CNBr-activated Sepharose
4B (Amersham Pharmacia Biotech).
For immunopurification of the
2 subunits, the protein fractions
(containing 1% of SDS, see above) were diluted 1/5 with 1% (w/v)
Triton X-100, 140 mM NaCl, 10 mM Tris-HCl, pH
7.4, and aliquots of 50, 100, and 200 µg of proteins were applied to
200 µl of affinity column. After overnight adsorption (at 4 °C),
the columns were extensively washed and eluted with 2% SDS in 10 mM Tris-HCl, pH 7.4. The eluted receptor was
electrophoresed and processed for immunoblot (25). For each
determination, one adult and one aged hippocampus were processed in
parallel. Importantly, the immunopurification approach was
quantitative, because after a first round of immunopurification, no
immunoreaction product (Mr 43,000 peptide) (24)
was detected in a second round of anti-
2 immunopurification (see
Fig. 3A). For the comparison between adult and aged rats,
three different aliquots were immunopurified and analyzed in parallel.
Other Methods--
Immunoblots, protein determination, and
SDS-polyacrylamide gel electrophoresis were done as described elsewhere
(24, 25). The statistical analysis of the data were performed using
one-way ANOVA or multifactor ANOVA and the Tukey post hoc multiple
comparisons test.
 |
RESULTS |
Expression of the GABAA Receptor Subunit
mRNAs--
The expression of different subunits of the
GABAA receptor was quantified by competitive RT-PCR using
cDNAs from hippocampus of 3-month-old (adult) and 24-month-old
(aged) rats. Fig. 1 shows a
representative experiment of the competitive RT-PCR analysis of the
5 subunit mRNA from one adult and two aged rats. This experiment
illustrates the linearity of the competitive RT-PCR (in the range
selected for each subunit of the GABAA receptor; see under
"Materials and Methods"), the experimental variability of
triplicate measurements, and also the differences between the adult and
the different aged samples. Thus, using this approach, we have
quantified the expression of eight subunits of the GABAA receptor complex (
1,
2,
3,
5,
2S,
2L,
2, and
3
subunits; the major subunits expressed at the hippocampal formation)
(29, 30) in a total population of four adults and five aged rats. As
shown, Fig. 2A, in the adult
and aged rats, the expression of the different GABAA
receptor subunits agrees with previous reports using in situ
hybridization (29). It is interesting to note the low interindividual
variation found in the four adults tested. The coefficients of
variation for each subunit (calculated as SD/mean) were 0.13, 0.11, 0.26, 0.16, 0.39, 0.24, 0.27, and 0.22 for
1,
2,
3,
5,
2
s,
2L,
2, and
3, respectively (mean, 0.22).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Representative quantification of the
GABAA receptor 5 subunit mRNA
levels in one adult and two different aged hippocampi.
A, representative films generated after the amplification of
a constant amount of cDNA (100 ng) in presence of four different
amounts of 5 internal standard. The PCR products were digested by
BglII and electrophoresed in agarose gels. The higher
molecular size band (338 bp) corresponded to native cDNA, and the
smaller product corresponded to the internal standard products (170 + 165 bp). B, the films (shown in A) were analyzed
by densitometry and the ratio of internal standard (absorbance)/sample
cDNA (absorbance) was plotted versus the amount of
internal standard used. The results are expressed as mean ± S.D.
of triplicate measurements. The point of equivalence (also shown in the
figure) was calculated after linear regression of the curves.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 2.
Age-dependent modification in the
expression of the hippocampal GABAA receptor subunits.
A, shown are the quantitative levels of the mRNAs coding
for eight GABAA receptor subunits from four adult
(open circles) and five aged (closed circles) rat
hippocampi. The results are shown individually and as mean ± SD
(bars). Note the difference in scale for both axis.
B, the percentage of variation (in relation to the adult
values) of the and 2 (S and L version) subunits was determined
individually for each analyzed rat. The coefficient of variation of the
adults for these subunits was also indicated in the figure.
|
|
By comparing all subunits in both ages, we observed a significant
increase in the aged population (multifactor ANOVA F (1,71) = 59.66, p = 0.00001) and also significant differences between subunits and ages (subunit × age, multifactor ANOVA F (7,71) = 55.36, p = 0.00001; Tukey p < 0.05).
When the expression of the total mRNA levels for the different
subunit families (i.e.
1 +
2 +
3 +
5,
2 +
3, and
2S + L) was analyzed, a significant increase in the aged
rats was observed for the
and
2 subunits (Table
I). The expression of the
GABAA receptor from aged hippocampus showed an important
high interindividual variability. The coefficients of variation,
calculated as above, for the expression of the different subunits in
the aged rats were 0.20, 0.12, 1.2, 0.26, 0.14, 0.28, 0.26, and 0.24 for
1,
2,
3,
5,
2 s,
2L,
2, and
3,
respectively (mean, 0.34). This high variability is likely due to the
aging process and not an artifact because of the competitive RT-PCR (see Fig. 1). Thus, we also analyzed individually the percentage of
variation (versus adult) in the expression of the
and
subunits. As shown in Fig. 2B, the expression of these
GABAA receptor subunits showed a clear tendency to increase
during aging. In fact, the expression of the
2S subunit increased
notably in the hippocampus from all five tested rats (see also Fig. 4,
in which a new aged sample was analyzed) (ranging from 190 to 320% of
the adult values; mean, 253.8 ± 53.9%; ANOVA F (1,7) = 69.33, p = 0.001; Tukey p < 0.01) with
no modifications in the expression of the long splicing version of this
subunit. Consequently, the S/L ratio (1.81 ± 0.7 versus 6.3 ± 1.9 for adult and aged rats,
respectively) also significantly increased in the aged hippocampi (F
(1,7) = 21.9, p = 0.002; Tukey p < 0.05).
View this table:
[in this window]
[in a new window]
|
Table I
Age-dependent modifications in the total mRNA content
of the different subunit families of the hippocampal GABAA
receptor
The total expression of the different subunit families was calculated
as the sum of the mRNA content of the different subunits tested
(e.g. 1 + 2 + 3 + 5; 2 + 3; 2s + 2L). The results are mean ± S.D. of four
and five different experiments for adult and aged rats, respectively.
|
|
On the other hand, the age-dependent modifications in the
expression of the different
subunits were highly heterogeneous (see
Fig. 2). The most common pattern of variation in the aged rats was an
increase in the
1 subunit mRNA (four of five animals; ranging
from 17 to 50%; mean, 32.5 ± 14.7%; significant difference from
adult, ANOVA F (1,6) = 9.59, p = 0.02; Tukey
p < 0.05). It is noteworthy that the single aged
hippocampus displaying no differences in the
1 level, rat 26, was
also the only aged rat showing a notable increase in the expression of
the
5 subunit (see Figs. 1 and 2; 61.1% over the adult value). It
is also interesting that in most cases (rats 7, 10, and 16), the
increment in the
1 subunit was also accompanied by an increase in
other
subunit(s) (see Fig. 2B), such as
2 (rats 10 and 16; 28 and 25% respectively) or
3 (rat 7; 700%).
Expression of the
2 and
1 Subunit Proteins--
We next
compared the expression of the proteins corresponding to
1 and
2
subunits, using the protein fractions obtained from the same
hippocampal samples as above (see under "Materials and
Methods").
Fig. 3C shows the
immunoreaction product corresponding to the immunopurified
2 subunit
(43 kDa), which clearly increased in the aged samples (compare
lanes 1-3 with 4-6). The difference between
both ages was calculated as the aged/adult ratio after the
densitometrical analysis of the films. As shown in Fig.
4A, there was a remarkable and
significant increase in the expression of the
2 subunit protein
(aged/adult ratio, 2.90 ± 0.62, n = 6, ranging
from 1.7 to 3.3; ANOVA F (1,8) = 26.43, p = 0.0009; Tukey p < 0.01). This increase was similar to
that detected at the mRNA level (
2S+L, aged/adult ratio,
2.40 ± 0.40, n = 6, Fig. 4A). When
these results were analyzed individually (Fig. 4B), the
alterations in mRNA and protein levels for the GABAA
receptor
2 subunit were found to vary in parallel.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 3.
The protein levels of both
2 and 1 subunits increased
in the aged hippocampus. The levels of 2 and 1 subunit
proteins were determined using specific antibodies by immunoaffinity or
immunoblot experiments. A, control experiments showing that
the anti- 2 immunoaffinity columns retained most, if not all, of the
2 subunit in single round of immunopurification. The protein
fraction, obtained after RNA isolation of an adult hippocampus, was
immunopurified through 200 µl of anti- 2 affinity column. The
supernatant of this purification was used in a second round of
incubation using the same amount of anti- 2 affinity column. Both
columns were washed and eluted with 2% SDS. The presence of the 2
subunit was analyzed by Western blot using a 1/5000 dilution of
anti- 2 antibody. As shown, a clear 43-kDa band was detected in the
first immunopurification (control), whereas no reaction
products were detected after the second immunopurification
(depleted). B, Western blot analysis of the 1
subunit using cortical membranes. Two different amounts of membranes
were subjected to Western blot with a 1/1000 dilution of anti- 1
antibody. This antibody recognized a band of 51 kDa ( 1), the
immunoreaction product increased in function of the protein loaded, and
this product is absent in absence of primary antibody or in presence of
anti- 1 plus peptide (not shown). C, representative
experiment of the anti- 2 (200-µl affinity column)
immunopurification procedure using three different amount of proteins
(50, 100, and 200 µg) from adult (lanes 1-3) and aged
(lanes 4-6) hippocampus processed in parallel. Note the
clear increase of the anti- 2 immunoreaction products in the aged
sample. A control of the anti- 2 immunoaffinity column, in the
absence of sample (lane 7), was also included. D,
Western blot analysis of the 1 content of a fixed amount of protein
(15 µg) from three adults (A2, A3, and A4: lanes 1, 4, and
7, respectively) and 7 aged samples (O1, O7, O10, O12, O26,
O16, and O26: lanes 2, 3, 5, 6, 8, 9, and 10, respectively). This experiment was repeated three times, in a similar
configuration, but testing all four control hippocampus. Note the clear
difference between the adult and aged samples on the pattern recognized
by anti- 1 antibody.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Age-related alterations on the expression of
the 2 subunit. A, shown are
the age-dependent variations, expressed as aged/adult
ratio, on 2 subunit mRNA (short + long isoforms) and protein.
The mRNA data were taken from Fig. 2 and protein variation were
calculated from experiments similar to that shown in Fig.
3C. Data are presented individually (closed
circles) or as mean ± SD (open bars).
B, the variations on the aged population (aged/adult ratio)
in both the 2 mRNA (open columns) and protein
(hatched columns) were represented individually for each
tested rat.
|
|
The
1 subunit was directly quantified by Western blots. The
anti-
1 antibody immunoreacted with a Mr
51,000 band (Fig. 3B, corresponding to the
1 subunit; see
also Refs. 24 and 25), and the immunoreaction product increased with
the amount of protein loaded in the gel. As also shown (Fig.
3B), no signal was detected in absence of antibody or by
preincubation of the anti-
1 antibody with the corresponding peptide
(data not shown, but see Ref. 25). As shown (Fig. 3D), in
the sample from adults, the anti-
1 antibody immunoreacted with a
major 51-kDa band and with a faint band of 53-54 kDa. This minor
component was not observed using total proteins from the adult rat
cortex (Fig. 3, B and D, CTX), membranes isolated from different rat brain areas, including hippocampus (31), or in
immunopurified receptors (see Ref. 25; also see Ref. 32). Interestingly, in all aged hippocampi, this 53-54-kDa band was strongly and consistently recognized by the anti-
1 antibody (see Fig. 3D). Furthermore, this 53-54 kDa band was observed in
the aged rats even using purified (through peptide columns) anti-
1 antibody (not shown). In the aged samples, the intensity of this immunoreaction product parallels that of the 51-kDa band. In fact, the
53-54-kDa band represented the 28.0 ± 5.8%, n = 6, of the 51 kDa. Although this band could be a different glycosylation form of the
1 subunit (32), the precise nature of this band is
currently unknown and was not considered for quantification.
The quantification of these experiments, shown in Fig.
5A, indicated the existence of
a moderate (aged/adult ratio, 1.27 ± 0.12, ranging from 1.05 to
1.40, n = 6) but significant (ANOVA F (1,10) = 4.9, p = 0.04; Tukey p < 0.05)
increase in the total content of
1 subunit in the aged hippocampus.
Furthermore, the age-dependent increase in the expression
of the
1 subunit also correlates with the variation in the mRNA
levels (aged/adult ratio, 1.26 ± 0.18, n = 5).
When the data were analyzed individually (see Fig. 5B),
variation on the mRNA levels was also reflected by a similar
modification at the protein level (e.g. rat 26).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Age-related alteration on the expression of
the 1 subunit. A, shown is the
variation (aged/adult ratio) of the mRNA and protein corresponding
to the 1 subunit (see legend of Fig. 4 for more details). Data are
presented individually (closed circles) or as mean ± SD (open bars). B, the variations on the aged
population (aged/adult ratio) in both the 1 mRNA (open
columns) and protein (hatched columns) were represented
individually for each tested rat. N.T., not tested.
|
|
Age-dependent Modifications of the Native
GABAA Receptor Complex--
We also tested the effect of
aging in the expression of these two subunits,
2 and
1, assembled
in native GABAA receptors. To this end, we analyzed the
[3H]flumazenil binding activity (10 nM)
immunoprecipitated by anti-
2 and anti-
1 antibodies from
hippocampal membranes of a new population of four adult and four aged
hippocampi. The results (see Table II)
demonstrated that both the [3H]flumazenil total binding
activity and the anti-
2 immunoprecipitated binding activity
(expressed in pmol/mg of solubilized protein) significantly decreased
in all four aged hippocampi tested. On the other hand, after two rounds
of incubation, the anti-
2 antibody immunoprecipitated most, if not
all, the [3H]flumazenil binding activity in both ages
(90.9 ± 7.2% and 91.5 ± 3.1% for adult and aged
hippocampi, respectively, see Table II) (see Ref. 23). As also shown
(Table II), there was a slight (and not statistically significant)
decrease on the [3H]flumazenil binding activity
immunoprecipitated by the anti-
1 antibody in the aged hippocampus.
This decrease was lower than that expected by the reduction of the
total [3H]flumazenil binding observed in the same
membrane preparation (-23.8 versus -8.6% for total and
anti-
1 immunoprecipitated binding activity, respectively; see Table
II). As a consequence, the proportion of [3H]flumazenil
binding activity immunoprecipitated by anti-
1 antibody increased
significantly in the aged samples (54.5 ± 3.8 versus 65.1 ± 5.6% for adult and aged; aged/adult ratio, 1.20 ± 0.10; see Table II). Interestingly, the increase in the
immunoprecipitation by anti-
1 was observed in three of the four aged
hippocampal samples tested, emphasizing the heterogeneity of the aging
process at the hippocampal formation (the individual data were 57.8, 71.4, 66.4, and 65.0% for the aged samples).
View this table:
[in this window]
[in a new window]
|
Table II
Total benzcdiazepine binding activity and anti- 2 or anti- 1
immunoprecipitation in adult and aged hippocampus
The isolated hippocampal membranes were solubilized, and the total
binding activity of 10 nM [3H]flumazenil were
determined. For immunoprecipitation experiments, 150 µg of
solubilized proteins were immunoprecipitated by two sequential
incubations with 50 µl + 50 µl of anti- 2 or 10 µl + 10 µl of anti- 1. The binding activity (10 nM
[3H]flumazenil) was determined in both pellets and in the
final supernatant. The results (mean ± S.D.) represent the
binding activity of the solubilized receptor (total binding) or the
cumulative immunoprecipitation and are expressed in pmol/mg solubilized
protein or percentage of immunoprecipitation.
|
|
These results demonstrated that the age-dependent increase
in the
2 subunit, mRNA and protein, was not reflected by a
similar increase of the
2 incorporated in the mature
GABAA receptor. Thus, the amount of
2 subunit, lacking
benzodiazepine binding activity, should increase in the aged
hippocampus. We tested this possibility by quantifying the volume (in
µl) of anti-
2 antiserum needed to immunoprecipitate a fixed (and
identical in both ages) amount of [3H]flumazenil binding
activity. As expected, Fig. 6, the
immunoprecipitation curves were clearly shifted to the right with no
changes in the maximal immunoprecipitation (see also Ref. 23)
(64.1 ± 3.6%, n = 3, and 58.5 ± 2.1%,
n = 3, for adult and aged hippocampi, respectively).
The curves were fitted to a monoexponential decay function, and the
volume of antibody that produces a half-maximal immunoprecipitation was
determined. The volume of anti-
2 for half-maximal
immunoprecipitation was 3.3 ± 0.7 µl, n = 3, and 8.5 ± 0.7 µl, n = 3, for adult and aged
hippocampus, respectively (significant difference between both ages;
ANOVA F (1,4) = 82.64, p = 0.0008; Tukey
p < 0.01). These results demonstrated the existence of
a significant increase in the amount of
2 subunit that exhibit no
binding activity (probably unassembled subunit). This increase (aged/adult ratio, 2.60 ± 0.21) is similar to that observed for
2S version at the mRNA level (3.53 ± 0.54) and the
2
protein (2.90 ± 0.62).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
Immunoprecipitation curves of the
anti- 2 antibody in adult and aged
hippocampus. The adult and aged hippocampal membranes were
solubilized, and a fixed amount of [3H]flumazenil (10 nM) binding activity (7, 500 ± 500 cpm), equal for
both ages, was immunoprecipitated with increasing volumes of anti- 2
antiserum. After immunprecipitation, the supernatants were collected
and the binding activity was determined. The results, expressed as a
percentage of the binding activity in absence of antibody, are shown as
mean ± SD of three different experiments in adults or
individually for the aged rats. All experiments were performed in
duplicate.
|
|
Expression of the AMPA Receptor Subunits--
The relative
proportion of the different subunits of the AMPA receptor (GluR1-4)
was studied using the cDNA from the same adult and aged hippocampal
preparations described in Fig. 2. As shown in Fig.
7A, the relative proportion of
the different AMPA receptor subunits, from both adult and aged
hippocampus, agree with that previously reported (33). As also shown,
no gross changes with aging were detected. Similarly to the
GABAA receptor, the coefficient of variation increased with
aging (0.05, 0.04, 0.04, and 0.5 for GluR1-4 in adults, respectively
(mean, 0.15), and 0.18, 0.05, 0.12, 0.66 for the same subunits in the
aged rats (mean, 0.25)) indicating the heterogeneity of the aging
process. Considering all subunits and both age groups, Fig.
7A, significant differences were observed (Multifactor ANOVA
Subunit × Ages F (3, 41) = 7.68, p = 0.004).
The proportion of GluR1 slightly decreased in the aged samples (ANOVA F
(1,10) = 8.87, p = 0.016; Tukey p < 0.05), whereas the GluR3 showed a tendency to increase (ANOVA F
(1,10) = 7.6, p = 0.02; Tukey p < 0.05). When the modifications (versus adult) were considered
individually (Fig. 7B), a predominant pattern was observed.
In all six animals, GluR1 decreased (ranging from -9 to -38%; mean,
-18.4 ± 13.4%), GluR3 increased (ranging from 20 to 65%; mean,
39.8 ± 15.3%), and GluR2 showed no variations (mean, -2.6 ± 4.5%). However, despite these age-dependent
modifications, we found no significant differences between either ages
in the (GluR1 + GluR3)/GluR2 ratio (GluR4 is a minor component of the AMPA receptor): 1.57 ± 0.17, n = 4, and 1.55 ± 0.17, n = 6, for adult and aged hippocampus,
respectively (Fig. 7). Thus, the calcium permeability of the AMPA
receptors seems not to be altered during aging.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Expression of the AMPA subunits in adult and
aged rat hippocampus. A, shown is the proportion of the
GluR1-4 AMPA receptor subunits expressed in the adult (open
circles) and aged (closed circles) rat hippocampus. The
results are shown individually and as mean ± SD (bars)
of at least five adult and six aged rats. B, the percentage
of variation (in relation to the adult values) of GluR1, GluR2, and
GluR3 subunits was determined individually for each analyzed rat. The
coefficient of variation of these subunits in the adult samples was
also indicated in the figure.
|
|
We also quantified the relative proportion between the flip/flop
splicing version of each subunit. No differences were observed (not shown).
Finally, the total expression of the AMPA receptor (GluR1 + GluR2 + GluR3 + GluR4 subunits) were determined in relation to the expression
of the
-actin. As shown in Fig. 8, no
age-dependent modifications were detected (AMPA/
-actin
ratio: 0.31 ± 0.04, n = 4, and 0.34 ± 0.05, n = 6, for adult and aged hippocampus, respectively).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 8.
Absence of variation on the expression of the
total AMPA receptor subunits and both GAD isoenzymes in the aged
hippocampus. The expression of total AMPA receptor subunits (GluR1 + GluR2 + GluR3 + GluR4) and both GAD isoenzymes (GAD65 and GAD67) were
determined in relation on the expression of the -actin. The results
(mean ± SD) from four adult and six aged samples are expressed as
the percentage of variation versus adult. For the -actin,
the PCR products from both ages were directly compared. Also, the
age-dependent variation on the 2S subunit of the
GABAA receptor was determined, in parallel, as internal
control of the method.
|
|
Expression of the GAD65/67 Isoenzymes--
The expression of both
isoforms of the GAD enzyme (GAD65 and GAD67) was also analyzed using
the same experimental approach as for the AMPA receptor in the same
adult and aged samples. The results (Fig. 8) indicate the absence of
significant differences between both ages.
 |
DISCUSSION |
In this study, we have determined the expression of eight subunits
of the GABAA receptor and all four subunit of the AMPA receptor in hippocampus from adult and six aged rats.
Age-dependent Modifications in the Expression of the
GABAA and AMPA Receptors--
The main observation of this
work is the existence of an age-related increase on the expression of
the
2S subunit and, to a minor degree, in the
1 subunit of the
hippocampal GABAA receptor, in absence of major
modification of the AMPA receptor, in the same aged hippocampi.
The mRNA (short version) and protein of the
2 subunit increased
dramatically in all aged hippocampal samples. Thus, in our rat
population, the increase in the expression of the
2 subunit could be
considered a hallmark of the aging process of the hippocampal GABAA receptor. On the other hand, the expression of the
different
subunits also increases with aging; however, this
increase is lower in magnitude and also varies between the different
aged animals. In most cases, two different
subunits increased; an increase in
1 subunit (mRNA and protein) was the most common pattern. The reason for this heterogeneous profile is not clear, but
this profile likely means that critical variables affecting the
GABAA subunit expression are different in the different
aged rats (see below).
The age-dependent modifications in the pharmacological (8,
9) and the electrophysiological (11) properties of the GABAA receptor are analogous to those found in the
substantia nigra in response to degeneration of the GABAergic striatal
afferents (34, 35). Indeed, the observed age-dependent
increase in the expression of the different GABAA receptor
subunits in the hippocampus could represent a normal response of the
neurons to a deafferentiation process. Interestingly, Shetty and Turner
(15) have demonstrated a decrease in the number of the GABAergic
neurons at the hippocampal formation of the aged rats. Thus, a decline
in the number of the interneurons could indicate a reduction of the
GABAergic inputs to the principal cells and, consequently, an increase
of the expression of the GABAA receptor complex. However,
in our adult and aged hippocampi, no apparent differences in the
expression of both GAD isoenzymes were observed. This discrepancy does
not invalidate our hypothesis because: (i) a deafferentiation process,
without net neuronal loss, would result in an increase of the
expression of the GABAA receptor, or (ii) it is possible
that the surviving interneurons increase the expression of these
isoenzymes compensating for the loss in the neuronal number (1). Thus,
we propose that the age-dependent increase of the
expression of the GABAA receptor subunits constitutes a
normal adaptive response of the principal cells to deficiencies on the
GABAergic system.
On the other hand, the age-dependent reduction in the
GABAergic cell number also was heterogeneous (15). Therefore, it is tempting to speculate that the high interanimal heterogeneity found in
the expression of the different
subunits may reflect the reduction
of different GABAergic populations and/or deafferentiation of a
particular subset of synaptic contact in the principal cells of the
aged hippocampus. In consequence, depending on the different GABAergic
synapses affected, the adaptive response may differ in the different
animals. It is important to emphasize the dramatic increase in the
expression of the
2 subunit (mRNA and protein) in all tested
aged hippocampi, indicating the existence of a similar process in the
whole aged population.
Our results also demonstrated the absence of major modifications on the
expression of the hippocampal AMPA receptor subunits in the same
animals. The absence of such modifications is consistent with previous
reports demonstrating the absence of changes of the
[3H]AMPA binding sites at the hippocampal formation (12,
13, 36) and suggest the absence of major modifications on the
excitatory inputs. This proposal is based on the fact that the
expression of the AMPA receptor subunits, GluR1 and GluR2/3, also
increased after deafferentiation (37). This conclusion is also in
accordance with the preservation of the principal neurons observed in
the aged animals (38).
We also observed a decrease in the relative proportion of the GluR1
subunit concomitant with an increase in the GluR3 subunit. These
modifications might reflect an increase on the excitability of the aged
hippocampus, because similar alterations (decrease in GluR1 and
increase in GluR3) have been reported in response to lesion-induced
limbic seizures (39) or in a pilocarpine model of spontaneous limbic
epilepsy (40).
As a whole, the observed age-dependent modifications in the
expression of both GABAA and AMPA receptor subunits
strongly suggest a preferential age-dependent alteration of
the GABAergic cells that could suggest a decrease in the inhibitory
system (see also Refs. 1, 41, and 42).
Age-dependent Modifications of the Mature
GABAA Receptor--
The increase in the expression of both
1 and
2 subunit, mRNA, and protein could have a direct
repercussion on the mature GABAA receptor in membranes.
Thus, we investigated the anti-
1 and anti-
2 immunoprecipitation
of the [3H]flumazenil binding activity, solubilized from
isolated membranes. We presume that only mature (assembled)
GABAA receptors display benzodiazepine binding sites (43,
44). In fact, our immunoprecipitation experiments demonstrated that the
increased expression of the
1 subunit was directly reflected by an
increase in the proportion of GABAA receptor containing
this subunit in the aged hippocampus, confirming previous
pharmacological and immunological experiments (8-10). Therefore, the
increased transcripted and translated
1 subunit is incorporated into
the assembled receptor, modifying the pharmacological and
electrophysiological properties of the GABAA receptor (8,
9, 11).
On the other hand, the increased expression of the
2 subunit is not
reflected by modifications in the mature GABAA receptor complex. The reduction of both the total and the anti-
2
immunoprecipitated [3H]flumazenil binding activity could
indicate the existence of an increase in the unassembled, or partially
assembled,
2 subunits (displaying no benzodiazepine binding
activity) as confirmed by the increase in the anti-
2 antibody volume
that produced a half-maximal immunoprecipitation in the aged
hippocampus. Therefore, the increase on the expression of the
2
subunit could result in an accumulation of this subunit in, probably,
intracellular compartments. We do not know the reasons for this
differential effect of aging on the incorporation of the
1 and
2
subunits to the mature receptors, but the extremely high increase on
the expression of the
2 subunit, more than 12 times higher than that
of the
subunits (see Table I) in the absence of apparent
modifications in the expression of the
subunits, could exceed the
capacity of the assembling process of the GABAA receptor.
In conclusion, our results demonstrated the existence of an
age-dependent increase on the expression of the
GABAA receptor subunits in the hippocampal formation with
minor modifications on the expression of the AMPA receptor. These
modifications indicate the existence of an specific alteration
(neuronal loss and/or deafferentiation) in the GABAergic system.
 |
ACKNOWLEDGEMENT |
We thank Dr. Jorgina Satrustegui for critical
reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by Grant 97/1303 from Fondo de
Investigaciones Sanitarias (to J. V.) and a contract from Ministero de
Educacion y Cultura to (D. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
34-95-4556770; Fax: 34-95-4233765; E-mail: vitorica@cica.es.
Published, JBC Papers in Press, April 5, 2000, DOI 10.1074/jbc.M000700200
 |
ABBREVIATIONS |
The abbreviations used are:
GABAA,
-aminobutyric acid, type A;
AMPA,
-amino-3-hydroxy-5-methylsoxazole-4-propionate;
bp, base pair(s);
RT, reverse transcription;
PCR, polymerase chain reaction;
ANOVA, analysis of variance;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
 |
REFERENCES |
| 1.
|
Barnes, C. A.
(1994)
Trends Neurosci.
17,
13-18
|
| 2.
|
Michaelis, E. K.
(1998)
Prog. Neurobiol.
54,
369-415
|
| 3.
|
Davies, P.,
Anderton, B.,
Kirsch, J.,
Konnerth, A.,
Nitsch, R.,
and Sheetz, M.
(1998)
Prog. Neurobiol.
55,
651-658
|
| 4.
|
Sieghart, W.
(1995)
Pharmacol. Rev.
47,
181-234
|
| 5.
|
Bonnert, T. P.,
McKernan, R. M.,
Farrar, S.,
Le Bourdelles, B.,
Heavens, R. P.,
Hewson, L.,
Rigby, M. R.,
Sirinathsinghji, D. J.,
Brown, N.,
Wafford, K. A.,
and Whiting, P. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9891-9896
|
| 6.
|
Dingledine, R.,
Borges, K.,
Bowie, D.,
and Traynelis, S. F.
(1999)
Pharmacol. Rev.
51,
7-61
|
| 7.
|
Greenblatt, D. J.,
Shader, R. I.,
and Harmatz, J. S.
(1989)
J. Clin. Pharmacol.
29,
866-872
|
| 8.
|
Ruano, D.,
Cano, J.,
Machado, A.,
and Vitorica, J.
(1991)
J. Pharmacol. Exp. Ther.
256,
902-908
|
| 9.
|
Ruano, D.,
Benavides, J.,
Machado, A.,
and Vitorica, J.
(1995)
J. Neurochem.
64,
867-873
|
| 10.
|
Gutierrez, A.,
Khan, Z. U.,
Ruano, D.,
Miralles, C. P.,
Vitorica, J.,
and Deblas, A. L.
(1996)
Neuroscience
74,
341-348
|
| 11.
|
Griffith, W. H.,
and Murchison, D. A.
(1995)
J. Neurosci.
15,
2407-2416
|
| 12.
|
Nicolle, M. M.,
Bizon, J. L.,
and Gallagher, M.
(1996)
Neuroscience
74,
741-756
|
| 13.
|
Magnusson, K. R.,
and Cotman, C. W.
(1993)
Neurobiol. Aging
14,
197-206
|
| 14.
|
Johnson, M.,
Perry, R. H.,
Piggott, M. A.,
Court, J. A.,
Spurden, D.,
Lloyd, S.,
Ince, P. G.,
and Perry, E. K.
(1996)
Neurobiol. Aging
17,
639-651
|
| 15.
|
Shetty, A. K.,
and Turner, D. A.
(1998)
J. Comp. Neurol.
394,
252-269
|
| 16.
|
Gutierrez, A.,
Khan, Z. U.,
Miralles, C. P.,
and Deblas, A. L.
(1996)
Mol. Brain Res.
35,
91-102
|
| 17.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
|
| 18.
|
Devaud, L. L.,
Smith, F. D.,
Grayson, D. R.,
and Morrow, A. L.
(1995)
Mol. Pharmacol.
48,
861-868
|
| 19.
|
Grayson, D. R.,
Bovolin, P.,
and Santi, M. R.
(1993)
Methods Neurosci.
12,
191-208
|
| 20.
|
Lambolez, B.,
Ropert, N.,
Perrais, D.,
Rossier, J.,
and Hestrin, S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1797-1802
|
| 21.
|
Bochet, P.,
Audinat, E.,
Lambolez, B.,
Crepel, F.,
Rossier, J.,
Lino, M.,
Tsuzuki, K.,
and Ozawa, S.
(1994)
Neuron
12,
383-388
|
| 22.
|
Ruano, D.,
Khan, Z. U.,
De Blas, A. L.,
Machado, A.,
and Vitorica, J.
(1994)
Eur. J. Pharmacol. Mol. Pharmacol.
267,
123-128
|
| 23.
|
Ruano, D.,
Araujo, F.,
Machado, A.,
Deblas, A. L.,
and Vitorica, J.
(1994)
Mol. Brain Res.
25,
225-233
|
| 24.
|
Araujo, F.,
Ruano, D.,
and Vitorica, J.
(1998)
Eur. J. Pharmacol.
347,
347-353
|
| 25.
|
Araujo, F.,
Tan, S.,
Ruano, D.,
Schoemaker, H.,
Benavides, J.,
and Vitorica, J.
(1996)
J. Biol. Chem.
271,
27902-27911
|
| 26.
|
Benke, D.,
Honer, M.,
Michel, C.,
and Mohler, H.
(1996)
Neuropharmacology
35,
1413-1423
|
| 27.
|
Stephenson, F. A.,
Duggan, M. J.,
and Pollard, S.
(1990)
J. Biol. Chem.
265,
21160-21165
|
| 28.
|
Pollard, S.,
Thompson, C. L.,
and Stephenson, F. A.
(1995)
J. Biol. Chem.
270,
21285-21290
|
| 29.
|
Wisden, W.,
Laurie, D. J.,
Mohler, H.,
and Seeburg, P. H.
(1992)
J. Neurosci.
12,
1040-1062
|
| 30.
|
Fritschy, J. M.,
and Mohler, H.
(1995)
J. Comp. Neurol.
359,
154-194
|
| 31.
|
Araujo, F.,
Ruano, D.,
and Vitorica, J.
(1999)
J. Pharmacol. Exp. Ther.
290,
989-997
|
| 32.
|
Buchstaller, A.,
Fuchs, K.,
and Sieghart, W.
(1991)
Neurosci. Lett.
129,
237-241
|
| 33.
|
Gold, S. J.,
Ambrosingerson, J.,
Horowitz, J. R.,
Lynch, G.,
and Gall, C. M.
(1997)
J. Comp. Neurol.
385,
491-502
|
| 34.
|
Sanna, E.,
Motzo, C.,
Usala, M.,
Pau, D.,
Cagetti, E.,
and Biggio, G.
(1998)
J. Neurochem.
70,
2539-2544
|
| 35.
|
Nicholson, L. F. B.,
Waldvogel, H. J.,
and Faull, R. L. M.
(1996)
Neuroscience
74,
89-98
|
| 36.
|
Magnusson, K. R.
(1998)
Mech. Ageing Dev.
104,
227-248
|
| 37.
|
Mizukami, K.,
Mishizin, A.,
Ikonomovic, M. D.,
Sheffield, R.,
and Armstrong, D. M.
(1997)
Brai |